Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00930839 · ClinicalTrials.gov registry record
Role of Prostaglandins on Niacin-Induced Flushing
A clinical trial, sponsored by Eastern Virginia Medical School.
- Completed
- Registry status
- 30
- Enrollment target
NCT00930839 is a clinical trial that has completed, run by Eastern Virginia Medical School. The registered enrollment target is 30 participants.
The verdict
NCT00930839 has completed, sponsored by Eastern Virginia Medical School.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study will focus on investigating the nicotinic acid stimulated release of prostaglandin D2 in normal controls. In subsequent studies, the investigators would like to further explore this pathway in people with type 2 diabetes. Enhanced blood flow (or flushing) may be compromised or exaggerated in type 2 diabetes particularly in those with impairment of autonomic function measured as the respiratory heart rate variability (HRV) of different frequencies reflecting the balance between the sympathetic and parasympathetic nervous systems. The investigators hypothesize that the vasodilatory effects induced by nicotinic acid will be different in glabrous and hairy skin and that autonomic imbalance may alter the response.
Interventions
- DRUG Niacin and aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00930839
The ClinicalTrials.gov registry entry for NCT00930839 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Virginia Medical School, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Niacin and aspirin is the first listed.
NCT00930839 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00930839 about?
NCT00930839 is a clinical study titled "Role of Prostaglandins on Niacin-Induced Flushing". This study will focus on investigating the nicotinic acid stimulated release of prostaglandin D2 in normal controls. In subsequent studies, the investigators would like to further explore this pathway in people with type 2 diabetes. Enhanced blood flow (or flushing) may be compromised or exaggerated...
What is the current status of trial NCT00930839?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2009-03. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00930839?
The interventions under investigation include: Niacin and aspirin (DRUG).
Who is sponsoring clinical trial NCT00930839?
This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.